Vigilin overexpression has been shown to be associated with hepatocellular carcinoma (HCC), the most common type of primary liver cancer, and occurs most often in people with chronic liver diseases, such as cirrhosis, and is the leading cause of liver cancer–related deaths worldwide (68). Here, HDLBP is linked to hepatocellular carcinoma.